Log in to save to my catalogue

Feasibility and potential diagnostic value of 18FPI-2620 PET in patients with down syndrome and Alzh...

Feasibility and potential diagnostic value of 18FPI-2620 PET in patients with down syndrome and Alzh...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3157555765

Feasibility and potential diagnostic value of 18FPI-2620 PET in patients with down syndrome and Alzheimer's disease: a case series

About this item

Full title

Feasibility and potential diagnostic value of 18FPI-2620 PET in patients with down syndrome and Alzheimer's disease: a case series

Journal title

Frontiers in neuroscience, 2024-01, Vol.18, p.1505999

Language

English

Formats

More information

Scope and Contents

Contents

Adults with Down Syndrome (DS) have a substantially increased risk for Alzheimer's disease (AD) due to the triplicated amyloid-precursor-protein gene on chromosome 21, resulting in amyloid and tau accumulation. However, tau PET assessments are not sufficiently implemented in DS-AD research or clinical work-up, and second-generation tau tracers such...

Alternative Titles

Full title

Feasibility and potential diagnostic value of 18FPI-2620 PET in patients with down syndrome and Alzheimer's disease: a case series

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_3157555765

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3157555765

Other Identifiers

ISSN

1662-4548

DOI

10.3389/fnins.2024.1505999

How to access this item